Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CT
- 22 August 2012
- journal article
- Published by Taylor & Francis Ltd in Current Eye Research
- Vol. 37 (12), 1171-1174
- https://doi.org/10.3109/02713683.2012.727521
Abstract
Purpose: To determine the anatomic characteristics and pharmacokinetic properties of intravitreally-placed aflibercept in a rabbit model. Materials and methods: Four Dutch-belted rabbits underwent intravitreal injection with I-124-aflibercept. Serial imaging with PET/CT imaging was performed on days 0, 2, 5, 7, 14, 21, 28 and 35. Measured radioactivity emission in becquerels/mL was used to calculate the half-lives for aflibercept. Results: I-124 aflibercept was confined within the vitreous cavity for the duration of the study. I-124 aflibercept could be detected in the vitreous cavity until day 28 and the average retention time with standard error after correction for radioactive decay was 4.58 ± 0.07 days. Conclusions: I-124 aflibercept was only visible in the vitreous cavity by PET/CT imaging following intravitreal injection. The retention properties were found to be comparable to those measured by other reported methods.Keywords
This publication has 10 references indexed in Scilit:
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis, 2012
- PET/CT Imaging of I-124–Radiolabeled Bevacizumab and Ranibizumab after Intravitreal Injection in a Rabbit ModelInvestigative Ophthalmology & Visual Science, 2011
- Effect of Contact Lens Power on Optical Coherence Tomography of the Retinal Nerve Fiber LayerInvestigative Ophthalmology & Visual Science, 2011
- 124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary resultsWorld Journal of Surgical Oncology, 2010
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in HumansAmerican Journal of Ophthalmology, 2008
- Comparison of Bevacizumab, Ranibizumab, and Pegaptanib In Vitro: Efficiency and Possible Additional PathwaysInvestigative Ophthalmology & Visual Science, 2008
- Pharmacokinetics and ocular tissue penetration of VEGF trap after intravitreal injection in rabbitsActa Ophthalmologica, 2008
- Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)Ophthalmology, 2007
- Pharmacokinetics of Intravitreal Bevacizumab (Avastin)Ophthalmology, 2007
- Ocular PharmacokineticsPublished by Springer Science and Business Media LLC ,1984